Clinical Trial Update: Verification of Predictive Biomarkers for Pancreatic Cancer Treatment Using Multicenter Liquid Biopsy

View source ↗

Summary

A completed multicenter study verifying predictive biomarkers for pancreatic cancer treatment using liquid biopsy.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Pancreatic Adenocarcinoma

Snippet

Sponsor: National Cancer Center, Korea | Conditions: Pancreas Adenocarcinoma | Status: COMPLETED